SCHEMBL30396756

SCHEMBL30396756

CCC(C[C@@H]1CCNC1=O)NC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.37
▸ CTSB P07858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6064485 0.88 CTSL (0.36) CTSLCTSB
SCHEMBL7417089 0.88 CTSL (0.36) CTSLCTSB
SCHEMBL19924782 0.88 CTSL (0.36) CTSLCTSB
SCHEMBL21772496 0.81 L3MBTL1 (0.35) CTSLCTSB
SCHEMBL21772494 0.81 L3MBTL1 (0.35) CTSLCTSB
SCHEMBL19586735 0.81 L3MBTL1 (0.35) CTSLCTSB
SCHEMBL30914037 0.80 CTSL (0.37) CTSLCTSB
SCHEMBL30914003 0.79 CTSL (0.41) CTSLCTSB
SCHEMBL27955014 0.77 CTSL (0.41) CTSLCTSB
SCHEMBL27955011 0.77 CTSL (0.41) CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4165037-A1 ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS Aligos Therapeutics, Inc. (US) 2023-04-19 — — EP disclosed
Send feedback